Advertisement

Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats

      Highlights

      • Wheel running is an effective method to assess inflammatory bowel disease in rats.
      • Trinitrobenzene sulphonic acid -induced inflammatory bowel disease depressed wheel running in adolescent and adult female rats.
      • Administration of Tetrahydrocannabinol exacerbated the depression of wheel running caused by inflammatory bowel disease.

      Abstract

      Inflammatory Bowel Disease (IBD) is a life-long disorder that often begins between the ages of 15 and 30. Anecdotal reports suggest cannabinoids may be an effective treatment. This study sought to determine whether home cage wheel running is an effective method to assess IBD, and whether Tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, can restore wheel running depressed by IBD. Adolescent and adult female Sprague-Dawley rats were individually housed in a cage with a running wheel. Rats were injected with trinitrobenzene sulphonic acid (TNBS) into the rectum to induce IBD-like symptoms. One day later, both vehicle and TNBS treated rats were injected with a low dose of THC (0.32 mg/kg, s.c.) or vehicle. Administration of TNBS depressed wheel running in adolescent and adult rats. No antinociceptive effect of THC was evident when administered 1 day after TNBS. In fact, administration of THC prolonged TNBS-induced depression of wheel running for over 5 days in adolescent and adult rats. These results show that home cage wheel running is depressed by TNBS-induced IBD, making it a useful tool to evaluate the behavioral consequences of IBD, and that administration of THC, instead of producing antinociception, exacerbates TNBS-induced IBD.

      Perspective

      This article advances research on inflammatory bowel disease in two important ways: 1) Home cage wheel running is a new and sensitive tool to assess the behavioral consequences of IBD in adolescent and adult rats; and 2) Administration of the cannabinoid THC exacerbates the negative behavioral effects of IBD.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abrams DI
        • Jay CA
        • Shade SB
        • Vizoso H
        • Reda H
        • Press S
        • Kelly ME
        • Rowbotham MC
        • Petersen KL
        Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial.
        Neurology. 2007; 68: 515-521
        • Brenna Ø
        • Furnes MW
        • Drozdov I
        • van Beelen Granlund A
        • Flatberg A
        • Sandvik AK
        • Zwiggelaar RTM
        • Mårvik R
        • Nordrum IS
        • Kidd M
        • Gustafsson BI
        Relevance of TNBS-colitis in rats: A methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD.
        PLoS ONE. 2013; 8: e54543
        • Catana CS
        • Magdas C
        • Tabaran FA
        • Crăciun EC
        • Deak G
        • Magdaş VA
        • Cozma V
        • Gherman CM
        • Berindan-Neagoe I
        • Dumitraşcu DL
        Comparison of two models of inflammatory bowel disease in rats.
        Adv Clin Exp Med. 2018; 27: 599-607
        • Cattaruzza F
        • Johnson C
        • Leggit A
        • Grady E
        • Schenk AK
        • Cevikbas F
        • Cedron W
        • Bondada S
        • Kirkwood R
        • Malone B
        • Steinhoff M
        • Bunnett N
        • Kirkwood KS
        Transient receptor potential ankyrin 1 mediates chronic pancreatitis pain in mice.
        Am J Physiol Gastrointest Liver Physiol. 2013; 304: G1002-G1012
        • El-Salhy M
        • Wendelbo IH
        • Gundersen D
        • Hatlebakk JG
        • Hausken T
        Evaluation of the usefulness of colonoscopy with mucosal biopsies in the follow-up of TNBS-induced colitis in rats.
        Mol Med Rep. 2013; 8: 446-450
        • Engels M
        • Cross RK
        • Long MD
        Exercise in patients with inflammatory bowel diseases: Current perspectives.
        Clin Exp Gastroenterol. 2018; 11: 1-11
        • Ghosh S
        • Mitchell R
        Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey.
        J Crohns Colitis. 2007; 1: 10-20
        • Hashash JG
        • Binion DG
        Exercise and inflammatory bowel disease: Insights into etiopathogenesis and modification of clinical course.
        Gastroenterol Clin North Am. 2017; 46: 895-905
        • Hegarty DM
        • Hermes SM
        • Morgan MM
        • Aicher SA
        Acute hyperalgesia and delayed dry eye after corneal abrasion injury.
        Pain Rep. 2018; 3: e664
        • Irving PM
        • Iqbal T
        • Nwokolo C
        • Subramanian S
        • Bloom S
        • Prasad N
        • Hart A
        • Murray C
        • Lindsay JO
        • Taylor A
        • Barron R
        • Wright S
        A randomized, double-blind, placebo-controlled, parallel-group, pilot study of cannabidiol-rich botanical extract in the symptomatic treatment of ulcerative colitis.
        Inflamm Bowel Dis. 2018; 24: 714-724
        • Izzo AA
        • Sharkey KA
        Cannabinoids and the gut: New developments and emerging concepts.
        Pharmacol Ther. 2010; 126: 21-38
        • Jones RCW
        • Otsuka E
        • Wagstrom E
        • Jensen CS
        • Price MP
        • Gebhart GF
        Short-term sensitization of colon mechanoreceptors is associated with long-term hypersensitivity to colon distention in the mouse.
        Gastroenterology. 2007; 133: 184-194
        • Kami K
        • Tajima F
        • Senba E
        Activation of mesolimbic reward system via laterodorsal tegmental nucleus and hypothalamus in exercise-induced hypoalgesia.
        Sci Rep. 2018; 8: 11540
        • Kandasamy R
        • Calsbeek JJ
        • Morgan MM
        Home cage wheel running is an objective and clinically relevant method to assess inflammatory pain in male and female rats.
        J Neurosci Methods. 2016; 263: 115-122
        • Kandasamy R
        • Dawson CT
        • Craft RM
        • Morgan MM
        Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat.
        Eur J Pharmacol. 2018; 818: 271-277
        • Kandasamy R
        • Lee AT
        • Morgan MM
        Depression of home cage wheel running: A reliable and clinically relevant method to assess migraine pain in rats.
        J Headache Pain. 2017; 18: 5
      1. Kandasamy R, Morgan MM: “Reinventing the wheel” to advance the development of pain therapeutics. Behav Pharmacol, Epub ahead of print, doi: 10.1097/FBP.0000000000000596.

        • Kikuchi A
        • Ohashi K
        • Sugie Y
        • Sugimoto H
        • Omura H
        Pharmacological evaluation of a novel cannabinoid 2 (CB2) ligand, PF-03550096, in vitro and in vivo by using a rat model of visceral hypersensitivity.
        J Pharmacol Sci. 2008; 106: 219-224
        • Kwilasz AJ
        • Negus SS
        Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.
        J Pharmacol Exp Ther. 2012; 343: 389-400
        • Lal S
        • Prasad N
        • Ryan M
        • Tangri S
        • Silverberg MS
        • Gordon A
        • Steinhart H
        Cannabis use amongst patients with inflammatory bowel disease.
        Eur J Gastroenterol Hepatol. 2011; 23: 891-896
        • Massa F
        • Marsicano G
        • Hermann H
        • Cannich A
        • Monory K
        • Cravatt BF
        • Ferri G-L
        • Sibaev A
        • Storr M
        • Lutz B
        The endogenous cannabinoid system protects against colonic inflammation.
        J Clin Invest. 2004; 113: 1202-1209
        • Morris GP
        • Beck PL
        • Herridge MS
        • Depew WT
        • Szewczuk MR
        • Wallace JL
        Hapten-induced model of chronic inflammation and ulceration in the rat colon.
        Gastroenterology. 1989; 96: 795-803
        • Naftali T
        • Mechulam R
        • Lev LB
        • Konikoff FM
        Cannabis for inflammatory bowel disease.
        Dig Dis. 2014; 32: 468-474
        • Naftali T
        • Mechulam R
        • Marii A
        • Gabay G
        • Stein A
        • Bronshtain M
        • Laish I
        • Benjaminov F
        • Konikoff FM
        Low-dose cannabidiol is safe but not effective in the treatment for Crohn's disease, a randomized controlled trial.
        Dig Dis Sci. 2017; 62: 1615-1620
        • Necefli A
        • Tulumoğlu B
        • Giriş M
        • Barbaros U
        • Gündüz M
        • Olgaç V
        • Güloğlu R
        • Toker G
        The effect of melatonin on TNBS-induced colitis.
        Dig Dis Sci. 2006; 51: 1538-1545
        • Ness TJ
        • Gebhart GF
        Colorectal distension as a noxious visceral stimulus: Physiologic and pharmacologic characterization of pseudaffective reflexes in the rat.
        Brain Res. 1988; 450: 153-169
        • Parra RS
        • Chebli JMF
        • Amarante HMBS
        • Flores C
        • Parente JML
        • Ramos O
        • Fernandes M
        • Rocha JJR
        • Feitosa MR
        • Feres O
        • Scotton AS
        • Nones RB
        • Lima MM
        • Zaltman C
        • Goncalves CD
        • Guimaraes IM
        • Santana GO
        • Sassaki LY
        • Hossne RS
        • Bafutto M
        • Junior RLK
        • Faria MAG
        • Miszputen SJ
        • Gomes TNF
        • Catapani WR
        • Faria AA
        • Souza SCS
        • Caratin RF
        • Senra JT
        • Ferrari MLA
        Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
        World J Gastroenterol. 2019; 25: 5862-5882
        • Pitzer C
        • Kuner R
        • Tappe-Theodor A
        EXPRESS: Voluntary and evoked behavioral correlates in neuropathic pain states under different housing conditions.
        Mol Pain. 2016; 12: 1-15
        • Pitzer C
        • Kuner R
        • Tappe-Theodor A
        Voluntary and evoked behavioral correlates in inflammatory pain conditions under different social housing conditions.
        Pain Rep. 2016; 1: e564
        • Quezada SM
        • Cross RK
        Cannabis and turmeric as complementary treatments for IBD and other digestive diseases.
        Curr Gastroenterol Rep. 2019; 21: 2
        • Ravikoff Allegretti J
        • Courtwright A
        • Lucci M
        • Korzenik JR
        • Levine J
        Marijuana use patterns among patients with inflammatory bowel disease.
        Inflamm Bowel Dis. 2013; 19: 2809-2814
        • Reddy SI
        • Wolf JL
        Management issues in women with inflammatory bowel disease.
        J Am Osteopath Assoc. 2001; 101: S17-S23
        • Rog DJ
        • Nurmikko TJ
        • Young CA
        Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial.
        Clin Ther. 2007; 29: 2068-2079
        • Sanson M
        • Bueno L
        • Fioramonti J
        Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats.
        Neurogastroenterol Motil. 2006; 18: 949-956
        • Seoane-Viaño I
        • Gómez-Lado N
        • Lázare-Iglesias H
        • Barreiro-de Acosta M
        • Silva-Rodríguez J
        • Luzardo-Álvarez A
        • Herranz M
        • Otero-Espinar F
        • Antúnez-López JR
        • Lamas MJ
        • Aguiar P
        • Fernández-Ferreiro A
        • Ruibal Á
        Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.
        Int J Pharm. 2018; 549: 335-342
        • Sexton M
        • Cuttler C
        • Finnell JS
        • Mischley LK
        A cross-sectional survey of medical cannabis users: Patterns of use and perceived efficacy.
        Cannabis Cannabinoid Res. 2016; 1: 131-138
        • Shi X-Z
        • Winston JH
        • Sarna SK
        Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis.
        Am J Physiol Gastrointest Liver Physiol. 2011; 300: G41-G51
        • Stevenson GW
        • Mercer H
        • Cormier J
        • Dunbar C
        • Benoit L
        • Adams C
        • Jezierski J
        • Luginbuhl A
        • Bilsky EJ
        Monosodium iodoacetate-induced osteoarthritis produces pain-depressed wheel running in rats: Implications for preclinical behavioral assessment of chronic pain.
        Pharmacol Biochem Behav. 2011; 98: 35-42
        • Storr M
        • Devlin S
        • Kaplan GG
        • Panaccione R
        • Andrews CN
        Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.
        Inflamm Bowel Dis. 2014; 20: 472-480
        • Swift W
        • Gates P
        • Dillon P
        Survey of Australians using cannabis for medical purposes.
        Harm Reduct J. 2005; 2: 18
        • Tappe-Theodor A
        • King T
        • Morgan MM
        Pros and cons of clinically relevant methods to assess pain in rodents.
        Neurosci Biobehav Rev. 2019; 100: 335-343
        • Tseng AH
        • Craft RM
        Sex differences in antinociceptive and motoric effects of cannabinoids.
        Eur J Pharmacol. 2001; 430: 41-47
        • Vilaseca J
        • Salas A
        • Guarner F
        • Rodriguez R
        • Malagelada JR
        Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis.
        Gastroenterology. 1990; 98: 269-277
        • Wallace JL
        • Keenan CM
        • Gale D
        • Shoupe TS
        Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis.
        Gastroenterology. 1992; 102: 18-27
        • Wallace JL
        • MacNaughton WK
        • Morris GP
        • Beck PL
        Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.
        Gastroenterology. 1989; 96: 29-36
        • Walsh Z
        • Callaway R
        • Belle-Isle L
        • Capler R
        • Kay R
        • Lucas P
        • Holtzman S
        Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use.
        Int J Drug Policy. 2013; 24: 511-516
        • Weiss A
        • Friedenberg F
        Patterns of cannabis use in patients with inflammatory bowel disease: A population based analysis.
        Drug Alcohol Depend. 2015; 156: 84-89
        • Zegre Cannon C
        • Kissling GE
        • Goulding DR
        • King-Herbert AP
        • Blankenship-Paris T
        Analgesic effects of tramadol, carprofen or multimodal analgesia in rats undergoing ventral laparotomy.
        Lab Anim (NY). 2011; 40: 85-93
        • Zhu X
        • Liu Z
        • Qin Y
        • Niu W
        • Wang Q
        • Li L
        • Zhou J
        Analgesic effects of electroacupuncture at ST25 and CV12 in a rat model of postinflammatory irritable bowel syndrome visceral pain.
        Acupunct Med. 2018; 36: 240-246